Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients
Clinical trial NCT05666258 · COMPLETED
Trial details
- NCT number
- NCT05666258
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-14
- Primary completion
- 2024-08-20
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.